Pyoderma gangrenosum es una enfermedad de la piel.

Same author

The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors.

The British journal of dermatology·2017

Same author

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

The British journal of dermatology·2017

Same author

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Same author

Response to Letter by Prof. C.B.B. Bunker.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Same author

Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Same author

Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.

Clinical and experimental dermatology·2016

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Pyoderma gangrenosum es una enfermedad de la piel.

Videos de Conceptos Relacionados

The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors.

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.

Response to Letter by Prof. C.B.B. Bunker.

Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.

Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Pyoderma gangrenosum es una enfermedad de la piel.

Videos de Conceptos Relacionados

Artículos Relacionados

The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors.

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.

Response to Letter by Prof. C.B.B. Bunker.

Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.

Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.